Nicholas D. Walter

ORCID: 0000-0003-0126-1993

Also affiliated with Rocky Mountain MS Center, University of Colorado Anschutz Medical Campus

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens”.

Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens

Nature Communications(2021)10.1038/s41467-021-22833-6

N/A

2.0DataRank · unranked

98 citations

Sarah E. M. Born, Gregory T. Robertson, Matthew J. Reichlen, Christian Dide-Agossou, Victoria Ektnitphong +36 more

Transcriptional adaptation of Mycobacterium tuberculosis that survives prolonged multi-drug treatment in mice

mBio(2023)10.1128/mbio.02363-23

N/A

0.536DataRank · unranked

17 citations

Christian Dide-Agossou, Matthew J. Reichlen, Karen Rossmassler, Reem Al Mubarak, Justin J. Reid +18 more

Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.02310-21

N/A

0.494DataRank · unranked

26 citations

Allison Bauman, Michelle E. Ramey, Karen Rossmassler, Reem Al Mubarak, Samantha Pauly +10 more

Transcriptional adaptation of drug-tolerant Mycobacterium tuberculosis in mice

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.06.531356

N/A

0.104DataRank · unranked

1 citations

Christian Dide-Agossou, Matthew J. Reichlen, Karen Rossmassler, Reem Al Mubarak, Justin J. Reid +16 more

Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.107875

N/A

0.104DataRank · unranked

1 citations

Lelia H. Chaisson, Zana Wangari Kiragu, Praewpannarai Buddadhumaruk, Ariana Austin, Yilan Gao +16 more

Mind the gap: Understanding discordance between culture- and a non-culture-based measure of bacterial burden in murine tuberculosis treatment models

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.18.695164

N/A

0.104DataRank · unranked

1 citations

A Friesen, Matthew J. Reichlen, Christian Dide-Agossou, Max McGrath, Ryan Peterson +5 more

Emergence of antibiotic-specific Mycobacterium tuberculosis phenotypes during prolonged treatment of mice

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01310-24

N/A

0DataRank · unranked

6 citations

Christian Dide-Agossou, Reem Al Mubarak, Karen Rossmassler, Victoria Ektnitphong, Allison Bauman +6 more

Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatment

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1667592

N/A

0DataRank · unranked

3 citations

Lisa K. Woolhiser, Vincent E. Guglielmi, Machenzie Wernsman, Ashley Romano, Samantha Pauly +5 more

Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108075

N/A

0DataRank · unranked

0 citations

Kelly E. Dooley, Wendy Carr, Jason E. Stout, Eric Nuermberger, Patrick Phillips +22 more

C-Reactive Protein Testing for Active Tuberculosis among Inpatients without HIV in Uganda: a Diagnostic Accuracy Study

Journal of Clinical Microbiology(2020)10.1128/jcm.02162-20

N/A

0DataRank · unranked

23 citations

Emmanuel Ochom, Patricia Turimumahoro, Patrick Byanyima, Ingvar Sanyu, Rejani Lalitha +10 more

Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.00492-25

N/A

0DataRank · unranked

0 citations

Christian Dide-Agossou, Reem Al Mubarak, Karen Rossmassler, Jo Hendrix, Martin I. Voskuil +6 more

Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of Mycobacterium tuberculosis Burden

Microbiology Spectrum(2021)10.1128/spectrum.00481-21

N/A

0DataRank · unranked

10 citations

Christian Dide-Agossou, Reem Al Mubarak, Karen Rossmassler, Abdul Wahab Ssesolo, Sylvia Kaswabuli +12 more

MOVER approximated CV: A tool for quantifying precision in ratiometric droplet digital PCR assays

Journal of Pharmaceutical and Biomedical Analysis(2022)10.1016/j.jpba.2022.114664

N/A

0DataRank · unranked

2 citations

Karen Rossmassler, Justin J. Reid, J. R. Purohit, Rada Savic, Payam Nahid +4 more

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00284-23

N/A

0DataRank · unranked

34 citations

Jackie P. Ernest, Christian Dide-Agossou, Allison Bauman, Michelle E. Ramey, Karen Rossmassler +12 more

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.03.527062

N/A

0DataRank · unranked

0 citations

Jackie P. Ernest, Christian Dide-Agossou, Allison Bauman, Michelle E. Ramey, Karen Rossmassler +12 more

Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.01010-23

N/A

0DataRank · unranked

10 citations

Andrés Obregón‐Henao, M. E. Ramey, Allie Bauman, Samantha Pauly, Karen Rossmassler +5 more